Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service cervical fusion & disc arthroplasty cases in New Hampshire: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 6% on average (210 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 5 | 282 | 21% |
| 2020 | 2 | 208 | 25% |
| 2021 | 4 | 258 | 29% |
| 2022 | 1 | 206 | 33% |
| 2023 | 3 | 190 | 37% |
| 2024 | 2 | 171 | 39% |
| 2025 from claims | – | 142 115–167 | 40% |
| 2026 forecast | – | 157 123–198 | 35% |
| 2027 forecast | – | 162 120–215 | 34% |
| 2028 forecast | – | 168 119–231 | 34% |
| 2029 forecast | – | 173 118–248 | 33% |
| 2030 forecast | – | 179 117–265 | 33% |
ACDF, posterior cervical fusion, cervical total disc replacement. Professional codes (what the surgeon bills): CPT 22551, 22600, 22856; the hospital bills MS-DRG 471, 472, 473, 429, 430.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in New Hampshire; 2 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 66% inpatient hospital, 34% hospital outpatient.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| New York | 35 | 1,875−1.6%/yr | −1.6%/yr | 1.0 | 2% | 1,980 in 2030+0.9%/yr |
| Pennsylvania | 23 | 1,803−4.6%/yr | −4.6%/yr | 1.3 | 0% | 1,920 in 2030+1%/yr |
| Massachusetts | 23 | 1,163−2.2%/yr | −2.2%/yr | 1.2 | 0% | 1,360 in 2030+2.6%/yr |
| New Jersey | 15 | 957+0.5%/yr | +0.5%/yr | 0.9 | 0% | 1,050 in 2030+1.5%/yr |
| Connecticut | 4 | 398−6.3%/yr | −6.3%/yr | 1.2 | 0% | 400 in 2030+0.2%/yr |
| Rhode Island | 0 | 112−1%/yr | −1%/yr | 1.2 | 0% | 210 in 2030+11%/yr |
| Maine | 0 | 110−11%/yr | −11%/yr | 0.7 | 0% | 160 in 2030+6.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 13 | 531−10%/yr | −10%/yr | 2.30.9× | 19% | 900 in 2030+9.2%/yr |
| Lumbar fusion | 6 | 324−6.1%/yr | −6.1%/yr | 1.40.7× | 0% | 500 in 2030+7.7%/yr |
| Kyphoplasty & vertebroplasty | 2 | 210−1.5%/yr | −1.5%/yr | 0.91.1× | 9% | 240 in 2030+2%/yr |
Cervical fusion & disc arthroplasty in every state, and its device makers · Every procedure market in New Hampshire · Every state · Compare with New York
Medtronic leads with 69% of company spending on these surgeons in 2025, −26 pts on 2024.
In 2025, 13 companies reported engagement with New Hampshire’s surgeons worth $54K in consulting, speaking, meals and travel tied to these products, about $27K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 69 clearances and approvals in the category, 4 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.